US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

296.31

+0.55000.19%

Post-market: 294.60-1.7100-0.58%19:41 EDT

Volume:260.53K

Turnover:75.10M

Market Cap:570.24M

PE:- -

High:300.34

Open:290.97

Low:281.50

Close:295.76

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.69

T/O Rate:13.54%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

IHH Healthcare's Attributable Profit Jumps 29% in Q2

MT Newswires Live

Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands

Simply Wall St.

Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target

Health Care Roundup: Market Talk

FDA Grants First Broad RAS Inhibitor Approval for Advanced Pancreatic Cancer, Cutting Mortality by 60% in Second-Line Setting

Huadong Medicine's Lymphoma Drug Gets US FDA's Fast Track Designation

MT Newswires Live

Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone

CSPC Innovation Pharma's Colorectal Cancer Drug Gets US FDA's Fast Track Designation; Shares Up 4%

MT Newswires Live

IHH Healthcare's 2QFY2026 patmi up 29% y-o-y

The Edge Singapore

Nicox Gets 2027 FDA Decision Date for Glaucoma Drug NCX 470

Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued?

Simply Wall St.

Promisia shareholders back acquisition and board fee increase at 2026 AGM

Alkane Resources Stock Tops Financially Strong Penny Stocks To Watch

Simply Wall St.

Ramsay Health Care (RMSYF) Receives a Hold from Citi

Sigma Healthcare-Chemist Warehouse Merger Delivers Strong First Full-Year Results

Ramsay Health Care Declares Interim Dividend of AUD 0.485 per Share

Health Care Down on Rotation Out of Biotech

Vital Healthcare Property Trust Opens Director Nominations Ahead of November AGM

Health Care Roundup: Market Talk

Revolution Medicines Earns Buy as RASONQUE FDA Approval and Strong Pricing Outlook Drive Price Target Increase to $315

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":296.31,"timestamp":1788206400000,"preClose":295.76,"halted":0,"volume":260525,"hourTrading":{"tag":"盘后","latestPrice":294.6,"preClose":296.31,"latestTime":"19:41 EDT","volume":1261,"amount":373361.52048,"timestamp":1788219685727,"change":-1.71,"changeRate":-0.005771,"amplitude":0.011137},"delay":0,"changeRate":0.0018596159047877042,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Post-Mkt","change":0.55,"latestTime":"08-31 19:54:07 EDT","open":290.97,"high":300.34,"low":281.5,"amount":75101085.83125001,"amplitude":0.0637,"askPrice":296.31,"askSize":100,"bidPrice":294,"bidSize":200,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":295.76,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003394,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":288.18,"preClose":295.76,"latestTime":"09:29 EDT","volume":1523,"amount":449603.04808999994,"timestamp":1788182999999,"change":-7.58,"changeRate":-0.025629,"amplitude":0.050003},"postHourTrading":{"tag":"盘后","latestPrice":294.6,"preClose":296.31,"latestTime":"19:41 EDT","volume":1261,"amount":373361.52048,"timestamp":1788219685727,"change":-1.71,"changeRate":-0.005771,"amplitude":0.011137},"volumeRatio":0.686734,"impliedVol":0.9253,"impliedVolPercentile":0.5737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.686734,"shares":1924486,"dividePrice":1.0056,"high":300.34,"amplitude":0.0637,"preClose":295.76,"low":281.5,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":296.31,"committee":0.333333,"eps":0,"divideRate":0.003394,"volume":260525,"delay":0,"ttmEps":0,"open":290.97,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":308.33,"twentyDayClose":228.04,"sixtyDayClose":179.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662770481","title":"IHH Healthcare's Attributable Profit Jumps 29% in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662770481?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:46","pubTimestamp":1787824019,"startTime":"0","endTime":"0","summary":"IHH Healthcare's  attributable profit to owners jumped 29% during the second quarter of the year to 573 million ringgit from 443 million ringgit a year earlier, according to a Thursday filing with the Malaysian Exchange.Earnings per share came in at 0.0648 ringgit compared with 0.0502 ringgit in the year-ago period.Revenue rose 12% year over year to 7.05 billion ringgit from 6.3 billion ringgit.The healthcare services provider declared an interim dividend of 0.055 ringgit per share for the period, payable by Oct. 30.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6092","BK4585","BK4137","LU0128526141.USD","BK6511","LU0029874061.USD","BK4588","LABU","Q0F.SI","XLV","XBI","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703987","title":"Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703987","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703987?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:22","pubTimestamp":1787822560,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals has doubled in the past year, yet the valuation checks send a more muted signal, with the stock screening as undervalued on earnings multiples but only showing a mixed overall value score. For investors, the question now is whether the recent rally has already captured much of the good news around the company.\n\nOver the past 12 months, Jazz Pharmaceuticals has delivered a return of about 100%, which puts the recent share price near the upper end of its one year range and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-stock-may-be-undervalued-as-fda-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-stock-may-be-undervalued-as-fda-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","JOYT","VOTE","GXDW","FEBU","DECU","BK4588","VGFPF","BK4007","LABU","RGLO","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","PMDE","LU0154245756.USD","IE00BN0W2T93.GBP","LU0889565916.HKD","BK4532","LU0320765992.SGD","LU0823416689.USD","LU0109394709.USD","LU0154245673.USD","JAZZ","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745297","title":"Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745297","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745297?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:35","pubTimestamp":1787819736,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan has maintained their bullish stance on RVMD stock, giving a Buy rating yesterday. Alec Stranahan ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-buy-rating-reiterated-as-fda-approval-and-strong-prelaunch-demand-support-unchanged-225-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-buy-rating-reiterated-as-fda-approval-and-strong-prelaunch-demand-support-unchanged-225-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771196","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771196","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771196?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:20","pubTimestamp":1787818800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0721 GMT - Novo Nordisk faces persistent concerns over the scope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0577902538.SGD","LU0762540952.USD","LU0648948544.HKD","LU2152927971.USD","LU0315178854.USD","LU0873338254.USD","LU0165289439.USD","LU2238330802.EUR","LU0211331839.USD","SG9999003826.SGD","LU1211504680.USD","BK6516","XLV","SG9999005177.SGD","LU0326948709.USD","LU0672654166.SGD","D05.SI","LU0823417737.USD","SG9999000475.SGD","LU0878005551.USD","LU1634259391.SGD","LU0048597586.USD","LU0543330483.HKD","BK6112","SG9999004220.SGD","LU0886674414.USD","LU1282649067.USD","SG9999001903.USD","BK6523","LU0011963245.USD","LU0588545490.SGD","LU0823038988.USD","SG9999008742.SGD","SGXZ58947870.SGD","XBI","BK4588","LU0210637038.USD","LU0061477393.USD","LU0577902454.USD","LU1282649810.SGD","SG9999003800.SGD","SG9999009443.AUD","LU0823417653.USD","SG9999000343.SGD","LU0823413587.USD","LU1497733631.SGD","SG9999004360.SGD","LU0955669360.SGD","LU0823413660.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164145033","title":"FDA Grants First Broad RAS Inhibitor Approval for Advanced Pancreatic Cancer, Cutting Mortality by 60% in Second-Line Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=1164145033","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164145033?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:01","pubTimestamp":1787817666,"startTime":"0","endTime":"0","summary":"On August 26, the U.S. Food and Drug Administration (FDA) granted approval to Revolution Medicines for its oral therapy Rasonque (generic name: daraxonrasib), designated for adults with metastatic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779426","title":"Huadong Medicine's Lymphoma Drug Gets US FDA's Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779426","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662779426?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:58","pubTimestamp":1787817488,"startTime":"0","endTime":"0","summary":"Huadong Medicine's  HDM2005 for injection obtained a fast track designation from the U.S. Food and Drug Administration, according to a Shenzhen bourse filing on Thursday.The drug is being developed as a treatment for patients with relapsed or refractory mantle cell lymphoma, who had at least two lines of systemic therapy, including a BTK inhibitor.The Chinese drugmaker's shares rose 1% at the close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0132","LU2328871848.SGD","BK0209","BK4588","000963","BK0187","BK0196","BK0188","BK0175","BK4585","LABU","LU1969619763.USD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158123171","title":"Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone","url":"https://stock-news.laohu8.com/highlight/detail?id=1158123171","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158123171?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:00","pubTimestamp":1787814046,"startTime":"0","endTime":"0","summary":"On August 27, the \"15th Five-Year Plan for Health Development in Fujian Province\" was officially released, outlining key initiatives for the upcoming period.Among the highlighted measures, the plan...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","HELX","BK4588","BK4581","IXJ","BK4550","XLV","159760","LABU","WDNA","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662483775","title":"CSPC Innovation Pharma's Colorectal Cancer Drug Gets US FDA's Fast Track Designation; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662483775","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662483775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:51","pubTimestamp":1787813504,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical's  first-in-class PD-1/IL-15 bispecific fusion protein, SYS6090 , received a fast track designation from the U.S. Food and Drug Administration, according to a Wednesday disclosure on the Shenzhen bourse.The Chinese pharmaceutical company's shares rose 4% during Thursday's afternoon trade.The drug is developed by the company's subsidiary, CSPC Giant Biopharmaceutical, as a treatment for patients with microsatellite-stable or mismatch repair-proficient metastatic colorectal cancer.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","300765","BK4585","BK0226","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058303","title":"IHH Healthcare's 2QFY2026 patmi up 29% y-o-y","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058303","media":"The Edge Singapore ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058303?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:34","pubTimestamp":1787812483,"startTime":"0","endTime":"0","summary":"\"We remain confident on reaching double-digit ROE by 2028,\" says group CEO Dr Prem Kumar Nair","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BK6092","LABU","BK4588","Q0F.SI","XLV","BK6511","BK4581","XBI","HCSG","BK4585","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662577328","title":"Nicox Gets 2027 FDA Decision Date for Glaucoma Drug NCX 470","url":"https://stock-news.laohu8.com/highlight/detail?id=2662577328","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662577328?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:18","pubTimestamp":1787811533,"startTime":"0","endTime":"0","summary":"An update from Nicox SA ( ($FR:ALCOX) ) is now available. Nicox SA said the U.S. Food and Drug Administration has accepted the New Drug Application...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nicox-gets-2027-fda-decision-date-for-glaucoma-drug-ncx-470?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nicox-gets-2027-fda-decision-date-for-glaucoma-drug-ncx-470?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745771","title":"Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745771","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:18","pubTimestamp":1787807892,"startTime":"0","endTime":"0","summary":"The latest move in Zymeworks (ZYME) stock comes after the U.S. FDA approved Ziihera, or zanidatamab hrii, for first line treatment of certain HER2 positive gastroesophageal cancers, triggering a US$250 million milestone from partner Jazz Pharmaceuticals.\nThe FDA decision appears to have reinforced investor confidence in Zymeworks, with the stock posting a 27.41% 1 month share price return and a 96.28% 1 year total shareholder return, while the 298.71% 3 year total shareholder return points to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","BK4139","ZYME","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778957","title":"Promisia shareholders back acquisition and board fee increase at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778957","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:17","pubTimestamp":1787807834,"startTime":"0","endTime":"0","summary":"An update from Promisia Healthcare Limited ( ($NZ:PHL) ) is now available. Promisia Healthcare Limited has reported that all resolutions put to sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-shareholders-back-acquisition-and-board-fee-increase-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-shareholders-back-acquisition-and-board-fee-increase-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AGM","BK4588","XLV","BK4195","XBI","BK4229","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662272723","title":"Alkane Resources Stock Tops Financially Strong Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662272723","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662272723?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:32","pubTimestamp":1787797966,"startTime":"0","endTime":"0","summary":"Oil price declines are easing some inflation worries, which keeps central banks guessing and investors hunting for pockets of potential growth at a discount. That is where the Financially Fit Penny Stocks screener can help. It filters for lower priced stocks with stronger balance sheets than many early-stage peers. This article highlights three of the most interesting candidates and what to watch before you consider them.\nThe three stocks in this article are just a small sample, and the full...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-tops-financially-strong-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-tops-financially-strong-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GDXY","AAAU","GDXJ","IAUI","DULL","BEGS","GDX","GLTR","SHNY","02840","GDXD","GOLY","CEF","IAU","YGLD","DBC","SGOL","MSB.AU","ALK.AU","BAR","SIG.AU","USG","GLL","UGL","GDXW","PPI","OUNZ","XBI","BGLD","FGDL","GLDM","GBUG","IAUM","PICK","XLV","XME","DGP","LABU","SGDM","BTGD","JNUG","DUST","DZZ","PHYS","JDST","RING","UYM","GDXU","GLD","GOAU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662263207","title":"Ramsay Health Care (RMSYF) Receives a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2662263207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662263207?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:35","pubTimestamp":1787790944,"startTime":"0","endTime":"0","summary":"In a report released today, Laura Sutcliffe from Citi maintained a Hold rating on Ramsay Health Care, with a price target of A$42.00. According to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","XLV","BK4588","BK4585","XBI","BK4185","RMSYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662725898","title":"Sigma Healthcare-Chemist Warehouse Merger Delivers Strong First Full-Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662725898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662725898?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:59","pubTimestamp":1787788766,"startTime":"0","endTime":"0","summary":"Sigma Healthcare Ltd ( ($AU:SIG) ) has issued an announcement. Sigma Healthcare Limited operates as a major pharmacy wholesaler and retail healthca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-chemist-warehouse-merger-delivers-strong-first-full-year-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-chemist-warehouse-merger-delivers-strong-first-full-year-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV","BK4588","BK4581","XBI","LABU","BK4585","LU0029874061.USD","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662723595","title":"Ramsay Health Care Declares Interim Dividend of AUD 0.485 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662723595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662723595?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:07","pubTimestamp":1787785640,"startTime":"0","endTime":"0","summary":"An update from Ramsay Health Care ( ($AU:RHC) ) is now available. Ramsay Health Care Limited has declared a fully paid ordinary dividend of AUD 0.4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-declares-interim-dividend-of-aud-0-485-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-declares-interim-dividend-of-aud-0-485-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","CROC","VIG","XBI","BK4588","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662474427","title":"Health Care Down on Rotation Out of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662474427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662474427?lang=en_us&edition=fundamental","pubTime":"2026-08-27 05:43","pubTimestamp":1787780580,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders rotated out of high-risk biotech stocks.Revolution Medicines shares rose after the biotech firm received commercial approval from the Food and Drug Administration for a pancreatic cancer pill touted by former Nebraska Sen. Ben Sasse as a \"miracle drug\" during his treatment.A cyberattack at medical-device maker Boston Scientific triggered a global outage of key operational technology, leaving the company unable to fill orders.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","XLV","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662742406","title":"Vital Healthcare Property Trust Opens Director Nominations Ahead of November AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662742406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662742406?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:53","pubTimestamp":1787777612,"startTime":"0","endTime":"0","summary":"An announcement from Vital Healthcare Property ( ($NZ:VHP) ) is now available. Vital Healthcare Property Trust has set its Annual Meeting for 10 No...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-opens-director-nominations-ahead-of-november-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-opens-director-nominations-ahead-of-november-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","VHP.NZ","BK4195","BK4229","XBI","BK8073","BK4581","XLV","AGM","LABU","BK8059","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874292","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874292?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:50","pubTimestamp":1787777400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0343 ET - WuXi XDC Cayman retains its bull at Citi Research on s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4588","BK4585","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662374230","title":"Revolution Medicines Earns Buy as RASONQUE FDA Approval and Strong Pricing Outlook Drive Price Target Increase to $315","url":"https://stock-news.laohu8.com/highlight/detail?id=2662374230","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662374230?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:25","pubTimestamp":1787775918,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines today and set a price target of $315.00. Charles Zhu has given ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-earns-buy-as-rasonque-fda-approval-and-strong-pricing-outlook-drive-price-target-increase-to-315-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-earns-buy-as-rasonque-fda-approval-and-strong-pricing-outlook-drive-price-target-increase-to-315-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","RVMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":6,"totalSize":392,"code":"91000000","status":"200"}]}}